Literature DB >> 25796220

Is Cold Loop Hysteroscopic Myomectomy a Safe and Effective Technique for the Treatment of Submucous Myomas With Intramural Development? A Series of 1434 Surgical Procedures.

Ivan Mazzon1, Alessandro Favilli2, Mario Grasso1, Stefano Horvath1, Gian Carlo Di Renzo2, Sandro Gerli3.   

Abstract

STUDY
OBJECTIVE: To assess the safety and efficacy of cold loop hysteroscopic myomectomy in a large series of cases.
DESIGN: Retrospective study (Canadian Task Force Classification III).
SETTING: Arbor Vitae Center for Endoscopic Gynecology, Rome, Italy. PATIENTS: A total of 1215 patients with 1 or more G1-G2 submucous myomas. INTERVENTION: Cold loop hysteroscopic myomectomy. MEASUREMENT AND MAIN
RESULTS: A total of 1690 myomas were removed. A minimum of 1 to a maximum of 5 fibroids for each surgical procedure were totally removed. Out of 1215 patients, 1017 (83.7%) were treated with a single surgical procedure. Twelve intraoperative complications occurred (0.84%). No cases of uterine perforation with the thermal loop or clinical intravasation syndrome were reported.
CONCLUSION: Cold loop hysteroscopic myomectomy seems to represent a safe and effective procedure for the removal of submucous myomas with intramural development, while at the same time respecting the anatomic and functional integrity of the myometrium. The use of a cold loop in resectoscopic myomectomy is associated with a low rate of minor intraoperative complications and an absence of major complications. This could be of primary relevance with a view to fertility and future pregnancies.
Copyright © 2015 AAGL. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cold loop; Hysteroscopic myomectomy; Hysteroscopy; Intraoperative complications; Uterine myoma

Mesh:

Year:  2015        PMID: 25796220     DOI: 10.1016/j.jmig.2015.03.004

Source DB:  PubMed          Journal:  J Minim Invasive Gynecol        ISSN: 1553-4650            Impact factor:   4.137


  7 in total

1.  Risk Factors for the Completion of the Cold Loop Hysteroscopic Myomectomy in a One-Step Procedure: A Post Hoc Analysis.

Authors:  Ivan Mazzon; Alessandro Favilli; Mario Grasso; Stefano Horvath; Vittorio Bini; Gian Carlo Di Renzo; Sandro Gerli
Journal:  Biomed Res Int       Date:  2018-05-20       Impact factor: 3.411

Review 2.  Hysteroscopic Morcellation of Submucous Myomas: A Systematic Review.

Authors:  Salvatore Giovanni Vitale; Fabrizio Sapia; Agnese Maria Chiara Rapisarda; Gaetano Valenti; Fabrizia Santangelo; Diego Rossetti; Benito Chiofalo; Giuseppe Sarpietro; Valentina Lucia La Rosa; Onofrio Triolo; Marco Noventa; Salvatore Gizzo; Antonio Simone Laganà
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

Review 3.  Uterine fibroid management: from the present to the future.

Authors:  Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Hum Reprod Update       Date:  2016-07-27       Impact factor: 15.610

4.  Clinical evaluation of improved MyoSure hysteroscopic tissue removal system for the resection of type II submucosal myomas.

Authors:  Yufei Liang; Yuefang Ren; Zeqiu Wan; Lihua Guo; Jie Dong; Yun Chen; Liping Lv
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

5.  Submucous Fibroids, Fertility, and Possible Correlation to Pseudocapsule Thickness in Reproductive Surgery.

Authors:  Andrea Tinelli; Ioannis Kosmas; Ospan A Mynbaev; Alessandro Favilli; Grigoris Gimbrizis; Radmila Sparic; Marcello Pellegrino; Antonio Malvasi
Journal:  Biomed Res Int       Date:  2018-09-03       Impact factor: 3.411

6.  The role of magnetic resonance-guided focused ultrasound in fertility-sparing treatment of uterine fibroids-current perspectives.

Authors:  Michał Ciebiera; Tomasz Łoziński
Journal:  Ecancermedicalscience       Date:  2020-05-06

7.  Likelihood of Accomplishing an In-Patient Hysteroscopic Myomectomy in a One-Step Procedure: A Systematic Review and Meta-Analysis.

Authors:  Ugo Indraccolo; Vittorio Bini; Alessandro Favilli
Journal:  Biomed Res Int       Date:  2020-01-08       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.